Turturro, Sanja B <br/><br/>
Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin.  [electronic resource] 

 -  Breast cancer research and treatment  Feb 2016 
 - 33-43 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-016-3729-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aspirin--pharmacology<br/>Breast Neoplasms--genetics<br/>Cell Proliferation--drug effects<br/>Class I Phosphatidylinositol 3-Kinases<br/>Cytostatic Agents--pharmacology<br/>Female<br/>Glycogen Synthase Kinase 3 beta--metabolism<br/>Humans<br/>MCF-7 Cells<br/>Mutation<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Phosphorylation<br/>Proto-Oncogene Proteins p21(ras)--genetics